Sat, Jan 31, 2015, 5:46 AM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

  • Tangible asset value = $1.58 per share

    Present value of future 10 year cash flows discounted at 9% = $6.30 per share

    Present value of future 10 year cash flows for pipeline adjusted statistically for probability of success = $16.50 per share.

    Value of Vertex = $24.38 per share

    So that is where the battle ground, if you use historical probabilities of clinical success of big pharma - you end up with a very low figure. If you assign a higher probability of success to the pipeline, you end up with a far higher number.

    What do you have in the near term to hold this up?


    Sentiment: Strong Sell

    SortNewest  |  Oldest  |  Most Replied Expand all replies
110.14-4.00(-3.50%)Jan 30 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.